Lower back pain (LBP) occurs in 80% of adults in their lifetime; resulting in LBP being one of
the biggest causes of disability worldwide. Chronic LBP has been linked to the degeneration …

Duchenne muscular dystrophy (DMD) is an X-linked disease caused by mutations in the
DMD gene and loss of the protein dystrophin. The absence of dystrophin leads to myofiber …

Duchenne muscular dystrophy (DMD) is a degenerative lethal, X-linked disease of skeletal
and cardiac muscles caused by mutations in the dystrophin gene. Cell therapy using …

In the recent times, stem cell biology has garnered the attention of the scientific fraternity and
the general public alike due to the immense therapeutic potential that it holds in the field of …

Duchenne muscular dystrophy (DMD) is an X-linked recessive disorder in which the loss of
dystrophin causes progressive degeneration of skeletal and cardiac muscle. Potential …

Li J, Ezzelarab MB, Cooper DKC. Do mesenchymal stem cells function across species
barriers? Relevance for xenotransplantation. Xenotransplantation 2012; 19: 273–285.© …

Volumetric muscle loss (VML) is a debilitating condition wherein muscle loss overwhelms
the body's normal physiological repair mechanism. VML is particularly common among …

After intra-arterial delivery in the dystrophic dog, allogeneic muscle-derived stem cells,
termed MuStem cells, contribute to long-term stabilization of the clinical status and …

Introduction Cell-based therapy was a promising treatment method for disc degenerative
diseases. Wharton's jelly cell (WJC) has been explored to cure various human diseases …

Mesenchymal stem cells (MSCs) and mesoangioblasts (MABs) are multipotent cells that
differentiate into specialized cells of mesodermal origin, including skeletal muscle cells …